riluzole has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole is a sodium-glutamate antagonist that attenuates neurodegeneration in amyotrophic lateral sclerosis (ALS)." | 3.30 | Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial. ( Aarabi, B; Ahmad, FU; Arnold, PM; Ball, J; Brodke, DS; Brooks, NP; Chow, DS; Fehlings, MG; Freeman, BJC; Guest, JD; Harrop, JS; Kopjar, B; Kurpad, SN; Moghaddamjou, A; Nassr, A; Ray, WZ; Schmitt, KM; Schuster, JM; Stanford, R; Toups, EG; Wilson, J; Wilson, JR; Yee, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fehlings, MG | 1 |
| Moghaddamjou, A | 1 |
| Harrop, JS | 1 |
| Stanford, R | 1 |
| Ball, J | 1 |
| Aarabi, B | 1 |
| Freeman, BJC | 1 |
| Arnold, PM | 1 |
| Guest, JD | 1 |
| Kurpad, SN | 1 |
| Schuster, JM | 1 |
| Nassr, A | 1 |
| Schmitt, KM | 1 |
| Wilson, JR | 1 |
| Brodke, DS | 1 |
| Ahmad, FU | 1 |
| Yee, A | 1 |
| Ray, WZ | 1 |
| Brooks, NP | 1 |
| Wilson, J | 1 |
| Chow, DS | 1 |
| Toups, EG | 1 |
| Kopjar, B | 1 |
1 trial available for riluzole and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial.
Topics: COVID-19; Double-Blind Method; Humans; Neuroprotective Agents; Pandemics; Prospective Studies; Riluz | 2023 |